Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
Unfortunately Stewart, the only people that have any influence here on the shore are the people that are in government…
Arguing with someone on here is one thing, but talking about their family members proves you're an ass.
Angry? I really do not care if you and your daddy evaporated into thin air last Wednesday at noon. My…
You mean he has some 'sugar in his tank'?
Sounds like Tanner Leatherman tiptoes through the tulips.